Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

OXFORD NANOPORE Aktie

 >OXFORD NANOPORE Aktienkurs 
1.744 EUR    +0.8%    (Tradegate)
Ask: 1.742 EUR / 1778 Stück
Bid: 1.706 EUR / 1818 Stück
Tagesumsatz: 18396 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>OXFORD NANOPORE Performance
1 Woche: +11,9%
1 Monat: +21,1%
3 Monate: +41,3%
6 Monate: +9,0%
1 Jahr: +38,4%
laufendes Jahr: +14,9%
>OXFORD NANOPORE Aktie
Name:  OXFORD NANOPORE TECHNOLOGIES
Land:  Großbritannien
Sektor:  Gesundheit
ISIN/ Wkn:  GB00BP6S8Z30 / A3C307
Symbol/ Ticker:  4R0 (Frankfurt)
Kürzel:  FRA:4R0, ETR:4R0, 4R0:GR
Index:  -
Webseite:  https://nanoporetech.com/
Marktkapitalisierung:  1420 Mio. EUR
Umsatz:  158.68 Mio. EUR
EBITDA:  -120.08 Mio. EUR
Gewinn je Aktie:  -0.165 EUR
Schulden:  39.81 Mio. EUR
Liquide Mittel:  293.09 Mio. EUR
Umsatz-/ Gewinnwachstum:  18.5% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  6.05 / 2.02 / -
Gewinnm./ Eigenkapitalr.:  -79.8% / -23.77%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  OXFORD NANOPORE
Letzte Datenerhebung:  05.07.25
>Eigentümer
Aktien: 961 Mio. St.
f.h. Aktien: 405.15 Mio. St.
Insider Eigner: 41.1%
Instit. Eigner: 46.01%
>Peer Group

 
12.06.25 - 18:03
Volta Labs Expands Long-Read Sequencing Capabilities with Automated Oxford Nanopore Library Prep App on Callisto™ (PR Newswire)
 
BOSTON, June 12, 2025 /PRNewswire/ -- Volta Labs, a genomics applications company, today announced the launch of its Library Prep App for Oxford Nanopore LSK114 on the Callisto™ Sample Prep System. This latest addition to the growing Volta apps menu extends Callisto's footprint in......
20.05.25 - 11:06
LONDON BROKER RATINGS: Kingfisher cut; Peel Hunt ups Oxford Nanopore (Alliance)
 
The following London-listed shares received analyst recommendations Tuesday morning and on Monday:----------FTSE 100----------Barclays cuts Kingfisher to 'underweight' (equal weight) - price target 280 (275) pence----------Deutsche......
06.05.25 - 10:54
LONDON BROKER RATINGS: Investec starts Oxford Nanopore with ′buy′ (Alliance)
 
The following London-listed shares received analyst recommendations Tuesday morning, Monday and on Friday:----------FTSE 100----------RBC cuts London Stock Exchange price target to 13,400 (14,000) pence -......
09.04.25 - 14:54
Oxford Nanopore teams up with Danaher subsidiary Cepheid (Alliance)
 
Oxford Nanopore Technologies PLC on Wednesday announced a collaboration aimed at advancing automated sequencing-based solutions.The Oxford-based specialist in DNA and RNA sequencing technologies said it......
09.04.25 - 13:01
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions (PR Newswire)
 
Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., April 9, 2025 /PRNewswire/ -- Oxford Nanopore Technologies, the company behind a new......
04.03.25 - 16:48
Gene-Sequencing Firm Oxford Nanopore Hit by US, China Turmoil (Bloomberg)
 
Gene-sequencing company Oxford Nanopore Technologies Plc's shares plunged the most in more than a year as uncertainty around cuts to US research funding and the impact of a global trade war eclipsed the firm's plans to forge ties with the pharmaceutical industry....
04.03.25 - 14:30
TECH Joins Forces With Oxford Nanopore Technologies: Stock to Gain? (Zacks)
 
Bio-Techne's Asuragen brand inks a partnership with Oxford Nanopore Technologies to launch research-use-only AmplideX Nanopore Carrier Plus Kit....
04.03.25 - 12:12
Oxford Nanopore closer to profitability after revenue growth in 2024 (Alliance)
 
Oxford Nanopore Technologies PLC on Tuesday reaffirmed its financial targets, projecting adjusted earnings before interest, tax, depreciation, and amortisation breakeven by 2027 and cash flow......
03.03.25 - 13:01
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes (PR Newswire)
 
AmplideX® Nanopore Carrier Plus Kit uses nanopore sequencing to resolve high-prevalence genes. MINNEAPOLIS and OXFORD, England, March 3, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, has teamed up with Oxford Nanopore......
14.01.25 - 11:36
Here’s why Oxford Nanopore Technologies stock is up 15% in the FTSE 250 (Fool)
 
This innovative FTSE 250 stock has had a solid start to the year, rising 15% in just two days. Is it time I considered adding it to my portfolio? The post Here's why Oxford Nanopore Technologies stock is up 15% in the FTSE 250 appeared first on The Motley Fool UK....
13.01.25 - 10:36
Oxford Nanopore buoyed by improved margins and strong sales growth (Alliance)
 
Oxford Nanopore Technologies PLC on Monday said it is on-track for financial breakeven in 2027, as it expects to report better-than-expected margins in 2024 alongside......
13.01.25 - 10:24
LONDON MARKET OPEN: European stocks open red; Oxford Nanopore shines (Alliance)
 
Blue chips in London, Paris and Frankfurt opened lower on Monday as UK Chancellor Rachel Reeves failed to lift the mood in the UK with......
27.11.24 - 12:30
Oxford Nanopore teams up with UK Biobank on epigenetic dataset (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
27.11.24 - 11:08
Geladanlage-Tipp: Gentechnikrevolutionär Oxford Nanopore auf dem Weg zum Bluechip (Manager-Magazin)
 
Mit der Technologie von Oxford Nanopore lassen sich menschliche DNA-Stränge künftig treffsicherer und billiger analysieren als bisher. Übersetzt in Kapitalmarktsprech: Ein Nebenwert könnte sich in einen Bluechip verwandeln....
11.11.24 - 12:12
Oxford Nanopore announces new executives in its leadership team (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
11.11.24 - 10:00
Oxford Nanopore jumps as new chief scientific, product officers named (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.24 - 08:10
Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK (Business Wire)
 
Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...
17.10.24 - 15:18
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing (GlobeNewswire EN)
 
AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the presentation of its latest research at the Molecular Analysis for Precision Oncology Congress – on October 16, 2024....
08.10.24 - 11:18
IN BRIEF: Oxford Nanopore set for FTSE 250 as shifts listing category (Alliance)
 
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...
10.09.24 - 16:36
Oxford Nanopore files to sue for patent infringement over nanopore sequencing technology (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!